Stifel raised the firm’s price target on Bausch + Lomb (BLCO) to $15 from $14 and keeps a Hold rating on the shares. B+L’s Miebo showed better-than-expected in the firm’s dry eye survey work, the analyst tells investors.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BLCO:
- BLCO Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- Bausch + Lomb price target raised to $21 from $19 at RBC Capital
- Bausch + Lomb Sets February Date to Report 2025 Results
- Bausch + Lomb price target raised to $19 from $17 at Goldman Sachs
- Evercore ISI upgrades four, downgrades six in MedTech and Tools